PMC6698276_01
(a) Front aspect of shoulder mass with significant difference compared to contralateral aspect. (b) Lateral aspect of shoulder mass. Frontal enlargement and a visivle erythema can be seen on the frontal aspect of the shoulder.
gr1.jpg
PMC6698276_01_gr1.jpg
fig0005
On physical examination, a mass was visible in the left shoulder (Fig. 1).
Radiograph of the left shoulder. An expansile and osteolytic lesion was visible with thinning of cortex in the proximal humerus.
gr2.jpg
PMC6698276_01_gr2.jpg
fig0010
Plain shoulder radiographs showed expansive and osteolytic lesion with thin cortex in the proximal humerus and discontinuity in some areas (Fig. 2).
Histopathologic section of Giant Cell tumor.
gr3.jpg
PMC6698276_01_gr3.jpg
fig0015
Open biopsy was performed and histopathological features indicated large giant cells containing multiple nuclei mixed with round mononuclear cells and neoplastic spindle mononuclear cells can be seen in Fig. 3. the patient had no prior medical illness.
Macro section of tumor after en-bloc resection showing the tumor, head of humerus and a portion of the normal bone.
gr4.jpg
PMC6698276_01_gr4.jpg
fig0020
During the rotator cuff muscle detachment, the meticulous hemorrhage control of anterior circumflex humeral artery, posterior circumflex humeral artery and cephalic vein to reach tumor site and tumor en-bloc resection was performed (Fig. 4).
Post-operative radiograph of the left shoulder.
gr5.jpg
PMC6698276_01_gr5.jpg
fig0025
The head of the implant was placed in the glenohumeral articulation joint (Fig. 5).
Range of Motion and clinical outcome at 3 months post operative.
gr6.jpg
PMC6698276_01_gr6.jpg
fig0030
Follow-ups were done on 3rd (Fig. 6) and 6th (Fig. 7) months to evaluate the function of left shoulder.